ADVERTISEMENT
Posted: Aug 9, 2024

New and Approved

Updates from FDA

Updates from FDA

Read more
Posted: Aug 9, 2024

Weight loss without a prescription

OTCs Today

Although GLP-1 receptor agonists are becoming more and more popular for weight loss, many patients are still looking for a nonprescription way to shed excess pounds. Numerous supplements are marketed for quickly burning fat, but only Alli, a half-strength OTC version of prescription orlistat (Xenical), is FDA-approved for weight loss.

Mary Warner

Read more
Posted: Aug 9, 2024

Tulsi for better sleep and stress relief

On The Shelf

Tulsi, the holy basil, is a supplement commonly sold as a tea and advertised as a way to boost a healthier immune system, relieve stress, and promote relaxation. Can this aromatic, perennial herb native to Southeast Asia provide overall relief?

Mickie Cathers

Read more
Posted: Aug 9, 2024

For smoking cessation, increasing treatment dose may help improve abstinence

Smoking Cessation

Combined nicotine replacement therapy (CNRT) and varenicline have been well established as first line options for smoking cessation. But which treatment regimen is best after an initial failure to abstain from smoking?

Lauren Howell, PharmD

Read more
Posted: Aug 9, 2024

Supervised exercise enhances long-term weight loss after a GLP-1 agonist

Weight Loss

Obesity medications such as GLP-1 receptor agonists can help patients lose significant amounts of weight. However, up to half of patients who take a GLP-1 stop taking it after a year, and often regain most of the weight they lost. Now a study published in the March 2024 issue of The Lancet suggests that engaging in supervised exercise while taking a GLP-1 may help patients maintain their weight loss even after they stop taking the medication.

Terri D’Arrigo

Read more
1234

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT